PetroChina Company Limited (PCCYF)

Verve Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	220,883	214,920	175,153	126,338	134,540	109,459
Market Cap Growth	-16.33%	22.70%	38.64%	-6.10%	22.91%	-25.11%
Enterprise Value	254,705	250,412	217,650	178,229	203,467	203,140
Last Close Price	0.97	0.77	0.66	0.45	0.43	0.30
PE Ratio	9.67	9.53	7.69	5.86	9.27	37.60
PS Ratio	0.56	0.53	0.41	0.27	0.33	0.37
PB Ratio	0.91	0.92	0.76	0.57	0.61	0.52
P/TBV Ratio	1.08	1.06	0.87	0.65	0.69	0.60
P/FCF Ratio	12.48	15.03	7.06	5.81	10.70	10.18
P/OCF Ratio	3.69	3.86	2.72	2.21	2.50	2.24
EV/Sales Ratio	0.65	0.62	0.51	0.38	0.49	0.69
EV/EBITDA Ratio	3.62	3.82	3.15	2.59	3.33	5.48
EV/EBIT Ratio	6.99	7.37	6.19	5.02	7.82	38.35
EV/FCF Ratio	14.39	17.52	8.77	8.19	16.19	18.89
Debt / Equity Ratio	0.21	0.21	0.25	0.29	0.33	0.37
Debt / EBITDA Ratio	0.73	0.72	0.82	0.92	1.17	1.95
Debt / FCF Ratio	2.84	3.41	2.35	2.99	5.89	7.10
Asset Turnover	1.03	1.07	1.11	1.25	1.05	0.74
Inventory Turnover	12.06	11.11	11.32	14.21	13.00	8.17
Quick Ratio	0.64	0.52	0.56	0.58	0.52	0.40
Current Ratio	1.05	0.93	0.96	0.98	0.93	0.80
Return on Equity (ROE)	10.70%	10.99%	11.39%	11.10%	8.27%	2.38%
Return on Assets (ROA)	5.56%	5.63%	5.74%	5.92%	4.14%	0.83%
Return on Capital (ROIC)	7.46%	7.54%	7.73%	7.93%	5.52%	1.09%
Return on Capital Employed (ROCE)	11.40%	11.70%	12.10%	12.00%	8.30%	1.80%
Earnings Yield	10.34%	10.50%	13.00%	17.07%	10.78%	2.66%
FCF Yield	8.02%	6.65%	14.17%	17.22%	9.34%	9.82%
Dividend Yield	-	8.36%	9.45%	13.75%	8.30%	8.84%
Payout Ratio	49.70%	50.01%	48.93%	36.77%	43.25%	147.73%
Total Shareholder Return	-	8.36%	9.45%	13.75%	8.30%	8.84%

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.